|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Telomerase activity in head and neck tumors after introduction of wild-type p53,p21,p16,and E2F-1 genes by means of recombinant adenovirus显示文摘 | Henderson YC Breau RL Liu TJ | 2000 | Head Neck2000，22，4： | 1 |
| 2 | MEK inhibitor PD0325901 significantly reduces the growth of papillary thyroid carcinoma cells in vitro and in vivo显示文摘 | Henderson YC Chen Y Frederick MJ | 2010 | Mol Cancer Ther2010，9，7： | 1 |
| 3 | Differential responses of human papillary thyroid cancer cell lines carrying the RET/PTCI rearrangement or a BRAF mutation to MEK1/2 inhibitors显示文摘 | Henderson YC Fredrick M J Clayman GL | 2007 | Arch Otolaryngol Head Neck Surg2007，133，8： | 1 |
| 4 | Detection of thyroid cancer stem cells in papillary thyroid carcinoma显示文摘 | Ahn SH Henderson YC Williams MD | 2014 | J Clin Endocrinol Metab2014，99，2： | 1 |
| 5 | Telomerase activity in head and neck tumors after introduction of wild-type p53, p21,p16, and E2F-1 genes by means of recombinant adenovirus 显示文摘 | Henderson YC Breau RL Liu TJ | 2000 | Head Neck2000，22，4： | 1 |
| 6 | Telomerase activity in head and neck tumors after introduction of wild-type p53, p21, p16,and E2F-1 genes by means of recombinant adenovirus显示文摘 | Henderson YC Breau RL Liu TJ | 2000 | Head Neck2000，22，4： | 1 |
| 7 | High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinoma显示文摘 | Henderson YC Shellenberger TD Williams MD | 2009 | Clin Cancer Res2009，15，2： | 1 |
| 8 | Genotypic analysis of tumor suppressor genes PTEN/MMAC1 and p53 in head and neck squamous cell carcinomas显示文摘 | HENDERSON YC WANG E CLAYMAN GL | 1998 | Laryngoscope1998，108，10： | 1 |
| 9 | Src inhibi- tors in suppression of papillary thyroid carcinoma growth 显示文摘 | Henderson YC Toro - Serra R Chen Y | 2014 | Head Neck2014，36，3： | 1 |
| 10 | Genotypic analysis of tumor suppressor genes PTEN/MMAC1 and P53 in head and neck squamous cell carcinomas显示文摘 | Henderson YC | | 0，，10： | 1 |
| 11 | High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinoma显示文摘 | Henderson YC Shellenberger TD Williams MD | 2009 | Clin Cancer Res2009，15，2： | 1 |
| 12 | High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinoma显示文摘 | Henderson YC SheIlenberger TD Williams MD etal | 2009 | Clin Cancer Res2009，15，2： | 1 |
| 13 | Genotypic analysis of tumor suppressor genes PTEN/MMAC1 and p53 in head and neck squamous cell carcinomas显示文摘 | Henderson YC Wang E Clayman GL | 1998 | Laryngoscope1998，108，10： | 1 |
| 14 | Telomerase activity in head and neck tumors after introduction of wild-type p53,p21,p16,and E2F-1 genes by means of recombinant adenovirus显示文摘 | Henderson YC Breau RL Liu TJ | 2000 | Head Neck2000，22，4： | 1 |
| 15 | Src inhibitors in suppression of papillary thyroid carcinoma growth显示文摘 | Henderson YC Toro-Serra R Chen Y | 2014 | Head Neck2014，36，3： | 1 |
| 16 | High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinoma显示文摘 | Henderson YC Shellenberger TD Williams MD | | 0，，02： | 1 |
| 17 | Differential responses of human papillary thyroid cancer cell lines carrying the RET/PTC1 rearrangement or a BRAE mutation to MEK1/2 inhibitors显示文摘 | Henderson YC Fredrick MJ Clayman GL | 2007 | Arch Otolaryngol Head Neck Surg2007，133，8： | 1 |
| 18 | High rate of BRAF and RET/PTC dual mutation associated with recurrent papillary thyroid carcinoma 显示文摘 | Henderson YC Shellenberger TD Williams MD | 2009 | Clin Cancer Res2009，15，2： | 1 |
| 19 | MEK inhibitor PD0325901 significantly reduces the growth of papillary thyroid carcinoma cells in vitro and in vivo显示文摘 | Henderson YC Chen Y Frederick MJ | 2010 | Mol Cancer Ther2010，9，7： | 1 |
| 20 | High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinoma显示文摘 | Henderson YC Shellenberger TD Williams MD | 2009 | Clin Cancer Res2009，15，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员